Actuate Therapeutics (ACTU) Q2 2026 Earnings

May 14Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.32
-0.29
-0.27
-0.24

Details

Expected EPS
-0.24
Actual EPS
-0.24
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Actuate Therapeutics⁩ (⁦ACTU⁩) has reported earnings of ⁦-0.24⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts